Blood Specimen Collection For Laboratory Assay Research
Launched by ROMAN HEALTH VENTURES INC. · Sep 13, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on collecting blood samples to help improve laboratory tests for various health conditions, including metabolic disorders, sexual dysfunction, and hair loss. Researchers are looking for healthy adults aged 18 and older who are willing to provide blood samples through simple fingersticks and standard blood draws. Participants will need to understand and sign a consent form and complete a brief health questionnaire.
To be eligible for the study, you should be generally healthy and able to attend one visit at the study lab or collect samples at home. However, individuals with certain health issues or those involved in other research studies may not qualify. If you choose to participate, you’ll play a crucial role in helping researchers develop and validate new lab procedures that could benefit many people in the future. Your involvement is important, and you will be guided throughout the process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any gender, in good general health
- • Must be 18 years old or older, inclusive at enrollment
- • Must be willing to provide capillary blood samples via a fingerstick and venous blood samples, including self-collection and collection by a licensed healthcare professional
- • Must be able to read, understand, and willingly sign an Informed Consent Form (ICF) and complete a brief health questionnaire
- • Must be able to read, speak and understand English
- • Must be available to attend one study visit at Investigator's laboratory or a third-party laboratory designated by the Investigator or collect samples at home, at the discretion of the Investigator.
- Exclusion Criteria:
- • Individuals who are unable to provide a blood sample due to any illness
- • Individuals participating in another research study, that the Investigator feels may compromise study outcomes
- • Individuals having an acute or chronic disease or medical condition, including pregnancy, which could excessively increase study risk in the opinion of the Investigator or compromise study outcomes
- • Individuals who are unlikely to be available for the duration of the study
About Roman Health Ventures Inc.
Roman Health Ventures Inc. is a pioneering healthcare company dedicated to transforming the delivery of medical services through innovative digital solutions. Focused on enhancing patient access and experience, Roman Health Ventures integrates telemedicine with evidence-based treatments to address a range of health concerns. The organization invests in and develops clinical trial programs that prioritize patient-centered care, leveraging advanced technology and data analytics to drive research and improve outcomes. With a commitment to advancing healthcare accessibility, Roman Health Ventures is at the forefront of redefining how patients engage with their health and wellness.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Nitin Vaswani, MD
Principal Investigator
Principal Investigator
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported